# Syed Rehman MD – FDA Inspection, Apr 3, 2018

Source: https://www.keypedia.com/records/fda_inspections/syed-rehman-md/34b0243f-f8e2-4bf7-a96e-b012c15c365b
Source feed: FDA_Inspections

> FDA inspection 1046633 of Syed Rehman MD, April 03, 2018. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046633
- Company Name: Syed Rehman MD
- Inspection Date: 2018-04-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1263609 - 2025-03-07
- FDA Inspection 717294 - 2011-04-01

## Related Officers

- [Company Rep](https://www.keypedia.com/people/craig-t-rybus/246aad79-6370-42e2-af6e-c0079c1bcbc6)

Company: https://www.keypedia.com/companies/syed-rehman-md/aedb124a-5616-47ec-a6df-cd1c015d3ec5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d